Jump Financial »

Enliven Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $699k 45k 15.40

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares 20 Year Treasury Bond ETF Etf (TLT)
NVIDIA Corp Common Stock (NVDA)
Walmart Common Stock (WMT)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)
Alibaba Group Holding Convertible bond (Principal)
Boston Scientific Corp Common Stock (BSX)
Energy Transfer Partnership Shares (ET)

View all positions for Jump Financial

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Vestal Point Capital
Fairmount Funds Management
BlackRock
Polar Capital Holdings
VR Adviser
Vanguard Group
Henderson Group
Point72 Asset Management
Novo A/S
Blackstone Group
Capital Research Global Investors
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics